Patent for HIV drug rejected, paves way for entry of generics | India News – Times of India
NEW DELHI: The Indian Patent Office has rejected the grant of a patent for dolutegravir, a crucial HIV drug marketed…
NEW DELHI: The Indian Patent Office has rejected the grant of a patent for dolutegravir, a crucial HIV drug marketed…